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Objective: To compare unbiased estimates of short- vs long-term cartilage loss in osteoarthritic knees.
Method: 441 knees [216 Kellgren Lawrence (KL) grade 2, 225 KL grade 3] from participants of the
Osteoarthritis Initiative were studied over a 4-year period. Femorotibial cartilage thickness was deter-
mined using 3 T double echo steady state magnetic resonance imaging, the readers being blinded to time
points. Because common measurement time points bias correlations, short-term change (year-1 to year-
2: Y1/ Y2) was compared with long-term change (baseline to year-4: BL/ Y4), and initial (BL/ Y1)
with subsequent (Y2/ Y4) observation periods.
Results: The mean femorotibial cartilage thickness change (standardized response mean) was 1.2%/
0.8% (0.42/0.28) over 1 (BL/Y1/Y1/ Y2), 2.1%/2.5% (0.56/0.55) over 2 (BL/Y2/Y2/ Y4),
3.3% (0.63) over 3 (Y1/ Y4), and 4.5% (0.78) over 4 years. Spearman correlations were 0.33 for
Y1 / Y2 vs BL / Y4, and 0.17 for BL / Y1 vs Y2 / Y4 change. Percent agreement between knees
showing progression during Y1/ Y2 vs BL/ Y4 was 59%, and 64% for BL/ Y1 vs Y2/ Y4. The area
under the receiver operating characteristic curve was 0.66 for using Y1/ Y2 to predict BL/ Y4, and
0.59 for using BL/ Y1 to predict Y2/ Y4 change.
Conclusion: Weak to moderate correlations and agreement were observed between individual short- vs
long-term cartilage loss, and between initial and subsequent observation periods. Hence, longer obser-
vation periods are recommended to achieve robust results on cartilage loss in individual knees. At cohort
and subcohort level (e.g., KLG3 vs KLG2 knees), the mean cartilage loss increased almost linearly with the
length of the observation period and was constant throughout the study.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Epidemiological studies and clinical trials make increasing use
of magnetic resonance imaging (MRI)-based measures of cartilage
morphology as a structural endpoint of osteoarthritis (OA) pro-
gression1e4. Such measures are used to identify risk factors of OA
progression and to evaluate the effect of disease modifying inter-
ventions. Studies have suggested that high rates of longitudinal
cartilage loss, measured quantitatively with MRI, were associatedto: F. Eckstein, Institute of
ergasse 21, A5020 Salzburg,
002-1249.
in).
s Research Society International. Pwith an increased risk of having total knee arthroplasty (TKA) in the
future5,6. Moreover, quantitative MRImeasures have been shown to
be sensitive to change over 1-year follow-up periods1e4,7e11.
Although short-term follow-up studies (e.g., 1 year) of cartilage
change are attractive for rapid results, the ratio of the true mean
change to the measurement’s precision error and to the variability
of true change among subjects is low. The latter is particularly
relevant if rates of change vary substantially over consecutive
short-term intervals within individuals due to intermittent OA
progression12. Measurement over longer study periods may over-
come these limitations, because the ratio between the “mean
measure change” and the “variability of the measured change”
becomes larger; this increases the power with which the effect of
an exposure on the outcome can be detected. However, long-termublished by Elsevier Ltd. All rights reserved.
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out, exceed conventional funding periods, and consume a greater
amount of the patent-life of a drug. They are therefore less attrac-
tive from an industry and funding agency perspective.
Clarifying whether short-term change (1 year) is an adequate
proxy of longer-term change is thus an important step in qualifying
a biomarker for use in short-term clinical studies. Evaluating the
consistency of rates of progression in consecutive time periods may
provide insights into the trajectory of OA progression, e.g., linear or
intermittent. Previous studies comparing rates of change for
cartilage morphology measures over different time intervals have
relied on common measurement points for these intervals, e.g., the
same baseline measurement for short- vs long-term change7e11, or
the same intermediate measurement for initial vs subsequent
change12. This involves a bias in estimates of the true correlation of
changes in different intervals: when the same baseline measure-
ment is used for calculation of short-termvs long-term changes, the
effect of baseline precision errors is in the same direction and the
true correlation between short- and long-term changes is over-
estimated. When changes in initial and subsequent intervals are
calculated using the same intermediate measurement, the preci-
sion error of the intermediate time point affects observed changes
in both observation periods in opposite directions, and the true
correlation may be underestimated or appear negative12.
Therefore, the current study was designed to address the
following questions:
(1) What is the magnitude of (subregional) femorotibial cartilage
thickness change in OA knees, and how large is the variability
of and sensitivity to change for 1-, 2-, 3-, and 4-year observa-
tion periods?
(2) How do results over these periods differ for Kellgren Lawrence
grade (KLG) 2 and KLG3 knees, and what are the numbers of
progressors vs non-progressors over different observation
periods?
(3) What is the correlation between short- vs long-term changes,
and what is the level of agreement in classifying knees as
progressors or non-progressors?
(4) What is the correlation between initial vs subsequent obser-
vation periods, and what is the level of agreement in classifying
knees as progressors or non-progressors?
Methods
Osteoarthritis initiative (OAI) cohort and sample selection
The data used for the study originate from the OAI, which is an
ongoing multi-center study (http://www.oai.ucsf.edu/) targeted at
identifying sensitive (imaging) biomarkers of onset and progres-
sion of knee OA. 4796 participants are studied using ﬁxed-ﬂexion
radiography13,14 and MRI of both knees15. OAI participants were
45e79 years old, with or “at risk of” symptomatic knee OA in at
least one knee. General exclusion criteria were presence of rheu-
matoid or other inﬂammatory arthritis, bilateral end-stage knee
OA, inability to walk without aids, and MRI contraindications.
Subjects selected for the current studywere fromtheprogression
subcohort (n ¼ 1390), based on having at least one knee with both
deﬁnite osteophytes16,17 and frequent symptoms at baseline. The
knee selected had to haveMRI acquisitions available at baseline (BL)
and year 1, 2 and 4 follow-up (Y1, Y2, Y4), frequent pain at baseline,
and a baseline KL grade of 2 or 318 based on central reading of serial
ﬁxed-ﬂexion knee radiographs13 at the Boston University Clinical
Epidemiology Research and Training Unit (for details please see
http://www.oai.ucsf.edu/datarelease/ImageAssessments.asp).MRI analysis
In the OAI, 3 T MRIs are generally available from BL to Y4 at 12
month intervals15,19. Amongst the different MRI sequences
acquired15,19 the double oblique sagittal double echo steady state
(DESS) water excitation sequence was used for cartilage segmen-
tation in the current study, as it has previously been validated in
context of quantitative cartilage analysis20,21. For blinding purposes,
the OAI coordinating center removed all links to acquisition dates
and participant ID in the image Digital Imaging and Communica-
tions in Medicine (DICOM) headers and shipped the images to the
analysis center (Chondrometrics GmbH, Ainring, Germany). After
initial quality control (MH), segmentation of the images was per-
formed by 12 readers who all had received formal training in
cartilage segmentation. A random time point was processed ﬁrst;
the other time points were then processed using the ﬁrst data set as
a reference, without knowledge of the order of acquisition. The
total area of subchondral bone (tAB) and the cartilage surface area
(AC) were segmented manually in the medial (MT) and lateral
tibiae (LT), and in the weight-bearing (central) part of the medial
(cMF) and lateral femoral condyles (cLF). The weight-bearing
aspect was separated from the posterior aspects of the condyles
using a 75% distance measure between the intercondylar notch and
their most posterior aspects, as described previously21,22. To mini-
mize segmentation errors and deviations between readers, all
segmentations were quality controlled by one expert (SM), also
with full blinding to time point of the MRI acquisition. tAB or AC
segmentations were corrected by the readers, if found necessary by
the expert. The mean cartilage thickness over the tAB (ThCtAB),
including denuded areas but excluding osteophytes was deter-
mined in each cartilage plate. Medial femorotibial compartment
(MFTC) cartilage thickness was computed as the sum of MT and
cMF, lateral femorotibial compartment (LFTC) cartilage thickness as
the sum of LT and cLF, and total femorotibial joint (FTJ) cartilage
thickness as the sum of MFTC and LFTC. Changes in central subre-
gions of MFTC (cMT and ccMF) and LFTC (cLT and ccLF)23 were
summarized as cMFTC and cLFTC24. Finally, the data were delivered
to the OAI coordinating center, and unblinding for the order of the
image acquisition times was done after the ﬁnal delivery had been
made and the data base had been locked.
The testeretest precision of theMRImeasurementmethodology
of articular cartilage morphology has been reviewed previously1,2,
with six to seven of the current team of 12 readers being involved in
recently published reproducibility studies20,24,25.
Statistical considerations and analysis
As part of the current study, 455 knees had cartilage
morphology data measured at all time points (BL, Y1, Y2 and Y4). Of
these, ﬁve were excluded due to BL / Y1 interval being shorter
than 10 months, and nine because both knees from the same
person had cartilage measurements, which cannot be viewed as
independent observations. In these latter cases, the right knees
were used, leaving 441 knees for analysis.
To allow for a comparison with data from prior studies, we
compared “observed” changes between BL and Y1 with “observed”
changes between BL and Y4 (BL / Y1 vs BL / Y4), although, as
argued above, this approach introduces a positive covariation,
because it uses the same baseline measurement for both intervals.
This effect is similar to the magnitude of the measurement error; it
biases the changes observed between the short (BL / Y1) and
long-term intervals (BL/ Y4) in the same direction and causes the
correlations of “observed” changes to systematically overestimate
the correlation of the “true” changes. To obtain unbiased estimates
of correlation between short- and long-term changes, the changes
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these do not share common measurement points.
To explore the relationship between changes in initial vs
subsequent time periods, we ﬁrst compared “observed” changes
during BL/Y1with Y1/ Y4, and BL/Y2with Y2/ Y4. Because
the shared intermediate measurement (Y1 or Y2) introduces
a degree of negative covariation that distorts “observed” changes
between the ﬁrst and the subsequent time interval in opposite
directions12, we compared BL/Y1 vs Y2/ Y4 to obtain unbiased
estimates. BL/ Y2 vs Y1/ Y4 was also studied for comparison.
The mean change in ThCtAB (mm) was determined as a measure
of the “magnitude of change”. Percent changes were derived by
relating themean change in a group to themean ThCtAB at baseline
for the same group, and 95% conﬁdence intervals (CI) for estimates
of change were determined using large sample binomial CI. The
standardized response mean [SRM, deﬁned as the mean change
divided by the standard deviation (SD) of change] was used as
a measure of the “sensitivity to change” for the total cohort, and for
KLG2 and KLG3 knees separately.
The correlation of the observed changes between different time
intervals was determined using non-parametric (Spearman’s rho)
coefﬁcients. The “smallest detectable change” (SDC) method26 was
used to identify knees with progression (i.e., with signiﬁcant loss of
ThCtAB) in the FTJ, in either compartment (MFTC and LFTC), and in
femorotibial cartilage plates (MT, cMF, LT, cLF). Cutpoints (change in
mm) for the dichotomous separation of progressors vs non-
progressors were derived from precision errors for repeated
measurements of DESS images in the OAI pilot study27 (testeretest
acquisitions at both BL and Y1 ¼ four measurements) as deﬁned by
Bruynestein et al.26 In Table II these cutpoints of change in ThCtAB
are listed for all regions of interest studied. The agreement of
“progression” in different time intervals was assessed by calcu-
lating the “overall percent agreement” [percentage of knees with
either progression (or non-progression) in both intervals, inTable I
Mean change in cartilage thickness (MC in mm and %) and standardized response mean
Joint BL/ Y1 Y1/ Y2 BL/ Y2
Region MC MC% SRM MC MC% SRM MC M
All knees (n ¼ 441) FTJ 88 1.2 0.42 61 0.8 0.28 149 2
MFTC 52 1.5 0.33 38 1.1 0.26 91 2
LFTC 36 0.9 0.30 22 0.6 0.17 58 1
cMFTC 105 2.5 0.42 69 1.7 0.30 173 4
cLFTC 61 1.2 0.34 43 0.9 0.22 104 2
MT 16 0.9 0.22 14 0.9 0.19 30 1
cMF 37 2.1 0.31 24 1.4 0.24 61 3
LT 22 1.2 0.34 19 1.0 0.26 41 2
cLF 13 0.7 0.16 3 0.2 0.04 16 0
KLG 2 (n ¼ 216) FTJ 43 0.6 0.23 42 0.6 0.21 86 1
MFTC 17 0.5 0.12 24 0.6 0.20 41 1
LFTC 27 0.7 0.26 18 0.5 0.15 45 1
cMFTC 43 0.9 0.21 44 1.0 0.23 87 1
cLFTC 47 0.9 0.27 36 0.7 0.18 84 1
MT 1 0.1 0.02 9 0.5 0.16 11 0
cMF 16 0.8 0.15 14 0.8 0.16 30 1
LT 18 0.9 0.28 19 1.0 0.27 37 1
cLF 9 0.4 0.12 1 0.0 0.01 8 0
KLG 3 (n ¼ 225) FTJ 131 1.9 0.59 78 1.2 0.34 209 3
MFTC 86 2.7 0.51 53 1.7 0.31 139 4
LFTC 44 1.2 0.34 26 0.7 0.20 70 1
cMFTC 163 4.4 0.61 93 2.6 0.35 256 7
cLFTC 74 1.5 0.40 49 1.0 0.25 123 2
MT 30 1.9 0.36 19 1.2 0.22 49 3
cMF 57 3.6 0.47 34 2.2 0.30 90 5
LT 27 1.5 0.40 18 1.1 0.25 46 2
cLF 17 0.9 0.19 7 0.4 0.09 24 1
FTJ ¼ femorotibial joint; MFTC ¼ medial femorotibial compartment; LFTC ¼ lateral fem
femorotibial compartment; LT¼ lateral tibia; cLF¼weight-bearing [central] lateral femor
of the MFTC/LFTC; BL ¼ baseline; Y1/Y2/Y4 ¼ year 1/2/4 follow-up.relation to the total number of knees], the “positive predictive
value” [PPV ¼ percentage of knees with progression in the shorter
(or initial) observation interval that also showed progression in the
longer (or subsequent) observation interval], the sensitivity, and
the speciﬁcity. Because all these agreement measures depend on
a speciﬁc threshold chosen (by the SDCmethod26), and because low
thresholds may inﬂate the calculated PPV, but impact sensitivity,
we additionally determined the receiver operating characteristics
(ROC) curves using a ﬁxed long-term and a variable short-term
threshold. Based on values for sensitivity and speciﬁcity, the area
under the ROC curve (AUC) was calculated, to assess the predictive
value of short-term loss for long-term changes.
Results
Of the 441 knees (230 right, 211 left) from 441 OAI participants
[191 men, 250 women; age (mean  SD) 60.9  8.8 years; body
mass index (BMI) 29.8  4.7] 216 were KLG2 (80 men, 136 women;
age 59.4  8.4 years; BMI 29.7  4.7) and 225 KLG3 (111 men, 114
women; age 62.3  9.0 years; BMI 29.9  4.6). The BL / Y1
observation period was 381  34 days, the Y1 / Y2 period
359  40 days, the BL/ Y2 period 740  33 days, the Y2/ Y4
period 728  40 days, the Y1/ Y4 period 1087  48 days, and the
BL/ Y4 period 1469  36 days.
Magnitude of change, sensitivity to change, percentage of progressor
knees
The mean change of ThCtAB in the FTJ (total cohort) was 1.2%
(95% CI ¼ 1.5%/0.9%) and 0.8% (95% CI ¼ 1.1%/0.6%) over
both 1-year periods (BL/ Y1, Y1/ Y2), 2.1% (95% CI ¼ 2.4%/
1.7%) and 2.5% (95% CI ¼ 2.9%/2.1%) over both 2-year periods
(BL/ Y2, Y2/ Y4), 3.3% (95% CI ¼ 3.8%/2.8%) over 3 years
(Y1 / Y4) and 4.5% (95% CI ¼ 5.0%/3.9%) over 4 years(SRM) over different intervals in different anatomical regions of the knee
Y2/ Y4 Y1/ Y4 BL/ Y4
C% SRM MC MC% SRM MC MC% SRM MC MC% SRM
.1 0.56 175 2.5 0.55 236 3.3 0.63 324 4.5 0.78
.7 0.45 107 3.2 0.48 145 4.3 0.55 198 5.8 0.62
.5 0.36 68 1.8 0.35 91 2.4 0.39 126 3.3 0.48
.2 0.53 178 4.5 0.51 246 6.1 0.61 351 8.5 0.69
.0 0.41 95 1.9 0.32 138 2.8 0.39 199 3.9 0.50
.8 0.36 42 2.5 0.43 56 3.4 0.49 72 4.3 0.58
.5 0.42 65 3.8 0.43 89 5.2 0.50 126 7.2 0.56
.2 0.48 40 2.2 0.44 58 3.2 0.53 81 4.4 0.63
.8 0.16 29 1.5 0.22 32 1.7 0.22 45 2.3 0.27
.1 0.38 128 1.7 0.36 171 2.2 0.43 214 2.8 0.52
.1 0.26 63 1.7 0.32 86 2.4 0.40 103 2.8 0.42
.1 0.32 66 1.7 0.29 84 2.1 0.33 111 2.8 0.41
.9 0.35 111 2.5 0.36 155 3.4 0.46 198 4.3 0.51
.6 0.33 97 1.8 0.29 133 2.5 0.35 181 3.4 0.43
.6 0.18 26 1.5 0.29 36 2.0 0.36 37 2.1 0.39
.6 0.25 36 1.9 0.28 51 2.7 0.34 66 3.5 0.37
.9 0.45 39 2.0 0.39 58 3.0 0.49 76 3.9 0.56
.4 0.09 27 1.3 0.19 26 1.3 0.16 35 1.7 0.22
.1 0.72 220 3.3 0.81 299 4.5 0.89 429 6.3 1.08
.4 0.61 149 4.9 0.63 202 6.5 0.69 288 9.1 0.82
.9 0.39 71 2.0 0.43 97 2.7 0.47 141 3.9 0.55
.0 0.68 242 7.1 0.65 334 9.5 0.75 498 13.5 0.87
.6 0.50 94 2.0 0.37 143 3.0 0.45 217 4.5 0.57
.1 0.50 57 3.7 0.57 76 4.9 0.60 106 6.6 0.75
.7 0.56 92 6.2 0.57 126 8.3 0.64 183 11.5 0.75
.6 0.50 40 2.3 0.50 58 3.4 0.58 86 4.9 0.70
.3 0.21 31 1.6 0.26 38 2.0 0.27 55 2.9 0.32
orotibial compartment; MT ¼ medial tibia, cMF ¼ weight-bearing [central] medial
otibial compartment; KLG¼ Kellgren Lawrence grade; cMFTC/cLFTC¼ central aspect
Table II
Number and percentage (%) of knees identiﬁed as progressors according to the smallest SDC method26 in different anatomical regions of the knee
Joint Threshold BL/ Y1 Y1/ Y2 BL/ Y2 Y2/ Y4 Y1/ Y4 BL/ Y4
Region mm N % N % N % N % N % N %
All knees (n ¼ 441) FTJ 226 109 25 83 19 149 34 155 35 181 41 225 51
MFTC 111 132 30 108 24 161 37 160 36 194 44 218 49
LFTC 121 97 22 88 20 111 25 128 29 136 31 160 36
MT 67 89 20 85 19 115 26 133 30 162 37 183 41
cMF 92 108 24 87 20 143 32 141 32 163 37 195 44
LT 74 80 18 81 18 122 28 115 26 149 34 188 43
cLF 116 41 9 42 10 57 13 67 15 87 20 88 20
KLG 2 (n ¼ 216) FTJ 226 31 14 34 16 49 23 55 25 63 29 86 40
MFTC 111 43 20 45 21 55 25 58 27 70 32 76 35
LFTC 121 39 18 38 18 43 20 53 25 58 27 71 33
MT 67 27 13 32 15 33 15 47 22 56 26 64 30
cMF 92 36 17 35 16 46 21 47 22 54 25 63 29
LT 74 35 16 39 18 53 25 50 23 67 31 86 40
cLF 116 14 6 16 7 19 9 26 12 34 16 30 14
KLG 3 (n ¼ 225) FTJ 226 78 35 49 22 100 44 100 44 118 52 139 62
MFTC 111 89 40 63 28 106 47 102 45 124 55 142 63
LFTC 121 58 26 50 22 68 30 75 33 78 35 89 40
MT 67 62 28 53 24 82 36 86 38 106 47 119 53
cMF 92 72 32 52 23 97 43 94 42 109 48 132 59
LT 74 45 20 42 19 69 31 65 29 82 36 102 45
cLF 116 27 12 26 12 38 17 41 18 53 24 58 26
BL ¼ baseline, Y1/Y2/Y4 ¼ year 1/2/4 follow-up; the threshold used for the identiﬁcation of progressors was computed using results from the OAI pilot study.
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Fig. 1. Bar graphs showing the magnitude of longitudinal change in cartilage thickness
thickness in the total femorotibial joint (top) and in FTJ, in the central medial femo-
rotibial (cMFTC) joint (bottom) (D ThCtAB in mm) over 1 year, 2 years, 3 years, and 4
years in knees with KLG 2 and 3, respectively. Changes between BL and Y1 follow-up
and between Y1 and Y2 were averaged to compute the 1-year change, and changes
between BL and Y2 and between Y2 and Y4 were averaged to compute the 2-year
change. Changes between Y1 and Y4 were used to compute the 3-year (3Y) and those
between BL and Y4 to compute the 4-year change (4Y).
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1-year, 0.56/0.55 for the 2-year, 0.63 for the 3-year, and 0.78
for the 4-year observation periods (Table I, Additional table is
included as Supplementary Material which shows 95% conﬁdence
intervals for all values in Table I). The magnitude of change
increased proportional to the observation period (Fig. 1), whereas
the SRM approximately doubled for a 4 vs 1-year observation
period (Table I).
Changes were greater in MFTC than in LFTC, greater centrally
(cMFTC/cLFTC) than in total compartments, and greater in KLG3
than in KLG2 knees; these differences were consistent across all
observation periods (Table I; Fig. 1). Amongst femorotibial plates,
the greatest changes were in cMF, and the smallest in cLF over all
observation periods. cMFTC was the (sub)region with the greatest
change; in KLG3 knees the mean change was 4.4% (95%
CI ¼ 5.4%/3.5%) and 2.6% (95% CI ¼ 3.6%/1.6%) over both 1-
year periods (BL/ Y1, Y1/ Y2), 7.0% (95% CI ¼ 8.3%/5.6%)
and 7.1% (95% CI ¼ 8.5%/5.6%) over both 2-year periods
(BL/ Y2, Y2/ Y4), 9.5% (95% CI ¼ 11.2%/7.8%) over 3 years
(Y1 / Y4), and 13.5% (95% CI ¼ 15.6%/11.5%) over 4 years
(BL / Y4). SRMs for cMFTC change in KLG3 knees were 0.61/
0.35 for the 1-year, 0.68/0.65 for the 2-year, 0.75 for the 3-
year, and 0.87 for the 4-year observation periods.
The percentage of knees showing progression above the SDC
threshold for FTJ were 25% and 19% for both 1-year periods
(BL/Y1, Y1/ Y2), 34% and 35% for both 2-year periods (BL/Y2,
Y2 / Y4), 41% over 3 years (Y1 / Y4), and 51% over 4 years
(BL / Y4; Table II). The greatest percentage of progressors was
observed in MFTC, and the lowest in cLF (Table II). KLG3 knees
showed greater number of progressors than KLG2 knees (12e40%
vs 6e20% for BL/ Y1; 26e63% vs 14e40% for BL/ Y4; Table II).
Relationship of changes between short- vs long-term observation
periods
Spearman correlation coefﬁcients for observation periods that
shared a common baselinemeasurement (e.g., BL/Y1 vs BL/Y4)
ranged from 0.42 (cLF) to 0.61 (cMFTC; Table III). The coefﬁcients
were lower for short- vs long-term periods that did not share the
same baseline measurement [e.g., Y1/ Y2 vs BL/ Y4: 0.21 (MT)
to 0.34 (LFTC); Table III; Fig. 2]. The correlations for Y1 / Y2 vs
Table III
Spearman correlation coefﬁcients (r) of changes in cartilage thickness in different anatomical regions of the knee between study intervals
Short-term vs long-term change Initial vs subsequent change
BL/ Y1 Y1/ Y2 BL/ Y1 BL/ Y2 BL/ Y1 BL/ Y2
BL/ Y4 BL/ Y4 Y1/ Y4 Y2/ Y4 Y2/ Y4 Y1/ Y4
All knees (n ¼ 441) FTJ 0.50 0.33 0.05 0.01 0.17 0.43
MFTC 0.56 0.29 0.01 0.05 0.23 0.40
LFTC 0.46 0.34 0.08 0.05 0.13 0.40
cMFTC 0.61 0.31 0.09 0.09 0.24 0.44
cLFTC 0.47 0.33 0.09 0.02 0.11 0.37
MT 0.46 0.21 L0.21 L0.13 0.11 0.27
cMF 0.60 0.29 0.03 0.08 0.24 0.42
LT 0.48 0.33 0.09 0.00 0.19 0.46
cLF 0.42 0.28 L0.21 L0.14 0.03 0.27
KLG 2 (n ¼ 216) FTJ 0.41 0.23 L0.21 0.11 0.07 0.31
MFTC 0.50 0.18 L0.22 0.16 0.08 0.24
LFTC 0.39 0.26 L0.22 0.12 0.09 0.33
cMFTC 0.53 0.18 0.15 0.15 0.10 0.23
cLFTC 0.46 0.26 0.17 0.12 0.06 0.29
MT 0.38 0.15 L0.38 L0.31 0.00 0.13
cMF 0.54 0.17 0.17 0.11 0.14 0.30
LT 0.51 0.26 0.09 0.03 0.24 0.46
cLF 0.27 0.24 L0.42 L0.27 0.08 0.15
KLG 3 (n ¼ 225) FTJ 0.54 0.37 0.01 0.02 0.18 0.47
MFTC 0.57 0.37 0.07 0.14 0.27 0.48
LFTC 0.52 0.41 0.03 0.01 0.15 0.46
cMFTC 0.64 0.39 0.19 0.19 0.30 0.54
cLFTC 0.48 0.39 0.03 0.06 0.14 0.45
MT 0.49 0.28 0.14 0.05 0.15 0.35
cMF 0.62 0.35 0.11 0.16 0.25 0.47
LT 0.45 0.39 0.09 0.04 0.13 0.45
cLF 0.54 0.31 0.03 0.03 0.13 0.37
BL ¼ baseline, Y1/Y2/Y4 ¼ year 1/2/4 follow-up. Bold and italic values indicate statistically signiﬁcant correlations (bold: P < 0.01; italic: P < 0.05).
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knees (0.15 to 0.26; Table III).
The overall percent agreement in progression/non-progression
in FTJ between Y1 / Y2 and BL / Y4 was 59%, the sensitivity
28%, the speciﬁcity 91%, the PPV 77%, and the AUC 0.66 for using
Y1/ Y2 to predict BL/ Y4. Percent agreement ranged from 60%
(MFTC) to 79% (cLF) between regions, and was greater for KLG2
than for KLG3 knees (Table IV).
Relationship of (individual) changes between consecutive
observation periods
The mean changes and number of progressors for Y1 / Y2
tended to be lower than those for BL/Y1, but were very similar for
Y2 / Y4 compared with BL / Y2 (Tables I and II). Spearman
correlation coefﬁcients between BL/ Y1 vs Y2/ Y4 ranged from
0.03 (cLF) to 0.24 (cMFTC and cMF), whereas lower (and generally
negative) correlations were observed for time periods that shared
a common intermediate time point (BL/Y1/Y1/ Y4 or BL/Y2/
Y2/ Y4; Table III). The correlations for BL/ Y1 vs Y2/ Y4 were
somewhat greater in KLG3 (0.13 to 0.30) than in KLG2 knees (0.08
to 0.24; Table III). The correlations for BL/ Y2 vs Y1/ Y4 were
substantially greater compared to those for BL/ Y1 vs Y2/ Y4
(Table III).
The overall percent agreement (FTJ) between BL / Y1 and
Y2/ Y4 was 64%, the sensitivity 34%, the speciﬁcity 80%, the PPV
48%, and the AUC 0.59 for using BL / Y1 to predict Y2 / Y4
change. Percent agreement ranged from 63% (MFTC) to 80% (cLF)
between regions, and again was greater for KLG2 than for KLG3
knees (Table IV).
Discussion
This is the ﬁrst study to report the correlation and agreement
of cartilage thickness loss over short-term (1 year) vs long-term(4 years), and between initial and subsequent follow-up
periods, with measurements not sharing a common (baseline or
intermediate) measurement point. At an empirical level, the
study conﬁrms that the use of common baseline measurement
overestimates the true correlation of short- vs long-term change7,
and that the use of a common intermediate measurement
underestimates the true correlation of initial vs subsequent
change12. Although the measurement error can still increase the
variation and attenuate the correlation for these comparisons,
this occurs to a much lesser degree than if a common baseline or
intermediate value is used.
441 knees from 441 participants of the OAI progression sub-
cohort with KLG 2 or 3 and frequent knee pain at baseline were
studied. In the other 534 participants of the OAI progression sub-
cohort, in whom at least one knee fulﬁlled the same criteria (KLG 2
or 3, and frequent knee pain), the age was 61.6  9.0 years and the
BMI 31.1  5.2 (61% women). In the entire progression subcohort
(57% women) the age was 61.4  9.1 years and the BMI 30.2  4.9.
The age and sex distribution of the current subsample was similar
(60.9 8.8 years; 57% women), whereas the BMI was slightly lower
(29.8  4.7) compared with the OAI progression subcohort partic-
ipants not studied. Nevertheless, given the large variation of BMI in
both subsamples, we feel the 441 subjects studied can be consid-
ered representative of the KLG2 and 3 knees of the OAI progression
subcohort.
The mean cartilage loss across the cohort increased almost
linearly with the length of the observation period, albeit the images
were read with full blinding of the image analysis center to the
acquisition order. Further, differences in cartilage thickness change
between femorotibial regions and between KLG2 and KLG3 knees
were consistent across all observation periods. The sensitivity to
change (SRM) also increased with longer observation periods, but
not proportionally to the increase in themagnitude of the thickness
change, because the SD of the change also increased. Comparisons
between observation periods that did not share common
Table IV
Agreement, sensitivity, speciﬁcity, positive predictive value (PPV), and area under the re
intervals determined using the SDC method26 in different anatomical regions of the kne
Short-term vs long-term change (Y1/ Y2 vs BL/
Agreement % Sensitivity % Speciﬁcity % PPV
All knees
(n ¼ 441)
FTJ 59.2 28.4 91.2 77.
MFTC 59.6 33.9 84.8 68.
LFTC 67.8 33.1 87.5 60.
MT 61.5 26.8 86.0 57.
cMF 61.0 28.2 87.0 63.
LT 64.9 30.3 90.5 70.
cLF 79.1 21.6 93.5 45.
KLG 2 (n ¼ 216) FTJ 65.7 26.7 91.5 67.
MFTC 65.3 30.3 84.3 51.
LFTC 68.1 28.2 87.6 52.
MT 67.6 20.3 87.5 40.
cMF 66.7 20.6 85.6 37.
LT 66.2 30.2 90.0 66.
cLF 82.4 13.3 93.5 25.
KLG 3 (n ¼ 225) FTJ 52.9 29.5 90.7 83.
MFTC 54.2 35.9 85.5 81.
LFTC 67.6 37.1 87.5 66.
MT 55.6 30.3 84.0 67.
cMF 55.6 31.8 89.2 80.
LT 63.6 30.4 91.1 73.
cLF 76.0 25.9 93.4 57.
BL ¼ baseline, Y1/Y2/Y4 ¼ year 1/2/4 follow-up. The agreement, sensitivity, speciﬁcity, a
progressors by the SDC method (see Table II). For abbreviations please see Table I.
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Fig. 2. Scatter plot showing the relationship between short term (Y1 / Y2) and
longterm (BL/ Y4) change in cartilage thickness (in mm) for Kellgren Lawrence grade
(KLG) 2 and KLG3 knees, respectively: (top) in the total femorotibial joint (FTJ);
(bottom) in the central medial femorotibial compartment (cMFTC).
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moderate correlations and agreement of progression are observed
between short- vs long-term change, and between initial vs
subsequent observation periods.
MRI-basedmeasures of cartilage thickness have previously been
shown to be sensitive to change over 1-year observation periods.
Annualized rates of change are, however, generally lower than the
precision errors of the measurements1,24,25,28. This provides
a plausible explanation as to why, at an individual knee level, only
weak to moderate correlations and agreement are observed
between short- and long-term cartilage loss, if no common baseline
measurement time point is used. Hence, contrary to previous
suggestions7, there appear to exist certain challenges in the use of
short-term individual (knee level) data to predict long-term indi-
vidual (knee level) cartilage loss. However, future improvements in
MR acquisition or image analysis technology might reduce
testeretest (reproducibility) errors of quantitative cartilage
measurements and may hence yield a greater association between
short- and long-term measurements of cartilage thickness change.
Only weak to moderate (positive) correlations and agreement
were observed between initial and subsequent observation periods,
when not using common intermediate time points. This may
partially result from OA progressing at a different (non-linear) pace
during subsequent follow-up period in individual knees. For the
reasons mentioned above, however, it is difﬁcult to accurately
estimate individual rates of progression in OA knees. This limits the
ability to reliably study the trajectory of OA progression (i.e., linear
vs intermittent) in individual knees. The correlations for BL/Y2 vs
Y1 / Y4 were substantially greater than those observed for
BL/ Y1 vs Y2/ Y4, likely because the observation periods were
partly overlapping, but also likely because comparison of the longer
(2 vs 3 year) observation periods is more robust and less sensitive to
precision errors than the shorter ones (1 vs 2 years). This nicely
demonstrates that longer observation periods are preferable to
obtain robust information on individual cartilage change
longitudinally.
As reported previously for 1-year observation periods29,30,
changes in cartilage thickness were consistently greater in KLG3ceiver operating characteristics curve (AUC) of progression throughout various time
e
Y4) AUC Initial vs subsequent change (BL/ Y1 vs Y2/ Y4) AUC
% Agreement % Sensitivity % Speciﬁcity % PPV %
1 0.66 63.7 33.5 80.1 47.7 0.59
5 0.63 63.3 40.6 76.2 49.2 0.63
2 0.65 65.3 28.1 80.5 37.1 0.57
6 0.58 67.3 29.3 83.8 43.8 0.58
2 0.65 67.6 37.6 81.7 49.1 0.63
4 0.67 73.5 33.9 87.4 48.8 0.61
2 0.68 79.6 13.4 91.4 22.0 0.55
6 0.62 68.5 16.4 86.3 29.0 0.53
1 0.59 67.1 25.9 82.3 34.9 0.60
6 0.61 68.5 22.6 83.4 30.8 0.54
6 0.53 72.2 14.9 88.2 25.9 0.53
1 0.62 72.7 25.5 85.8 33.3 0.59
7 0.66 76.4 34.0 89.2 48.6 0.64
0 0.67 83.3 7.7 93.7 14.3 0.47
7 0.68 59.1 43.0 72.0 55.1 0.60
0 0.64 59.6 49.0 68.3 56.2 0.61
0 0.68 62.2 32.0 77.3 41.4 0.58
9 0.61 62.7 37.2 78.4 51.6 0.58
8 0.66 62.7 43.6 76.3 56.9 0.63
8 0.68 70.7 33.8 85.6 48.9 0.58
7 0.68 76.0 17.1 89.1 25.9 0.60
nd PPV were calculated using the number of knees classiﬁed as progressors or non-
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Further, the relative difference in progression between the two
subcohorts was consistent across the various observation intervals.
This demonstrates that, once observed rates of change are averaged
across a number of individual knees prediction of subsequent rates
of change becomes more reliable. It further demonstrates that risk
factors of cartilage loss, such as joint space narrowing at baseline
(KLG3 vs KLG2), can be effectively detected using short-term (i.e., 1
year) observational cartilage thickness data. As precision errors
have been reported to be similar for KLG2 and 325, higher rates of
change in KLG3 knees are likely responsible for the greater corre-
lations between short- and long-term change compared with KLG2
knees, given a more favorable relationship between the magnitude
of change and the precision error.
The magnitude of change observed in the cohort during the ﬁrst
year was somewhat greater than that during for the second year;
however, the ﬁrst year observation period was also longer than the
second year period. During both 2-year observation periods, which
were similar in length, rates of change were remarkably similar.
This ﬁnding of consistent rates of change over several observation
periods resolves discrepancies from earlier studies in smaller
cohorts, some of which reported greater (annualized) rates of
change for short (6 months) vs longer-term observation periods (24
months)8e10 while other found the opposite11. Hence, there is no
indication that the mean rate of cartilage loss in OA knees varied
throughout this 4-year study. These observations conﬁrm that the
mean rate of cartilage loss in knee OA observed over the short term
accurately reﬂect those to be expected over long-term periods.
Further, there is no evidence that rates of change increase or
decrease over time, or with shorter or longer observation periods.
The SRM did not increase linearly, but roughly by a factor of 1.5
when the observation period was doubled. Because the mean
changes were similar for subsequent observation intervals of equal
length and because image analysis-related precision errors can be
assumed to be similar for short- and long-term observation periods,
this ﬁnding suggests that the SD of change between individual
knees increases over time in clinical studies. Therefore, the ability
to discriminate drug effects or risk factors of OA does not increase
linearly with the length of the observation period, and therefore the
increased cost of a longer study needs to be carefully balanced
against the actual gains in statistical power.
In conclusion, this study provides unbiased estimates of
observed change in cartilage thickness for short- vs long-term and
for initial vs subsequent observation periods in OA knees, without
sharing common baseline or intermediate time points. Weak to
moderate correlationswereobservedbetween short- and long-term
cartilage thickness change, and between initial vs subsequent
observationperiods in individual knees. Theseﬁndings suggest that,
at an individual knee level, 1-year measurements of cartilage
thickness change cannot be viewed as a reliable proxy of long-term
change. Longer observation periods hence appear to be required to
achieve robust results in individual knees. At a cohort and subcohort
level (e.g., KLG3 vs KLG2 knees), however, femorotibial cartilage loss
increased almost linearly with the length of the observation period
and was constant throughout the 4-year study.Author contribution
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